ORAL SEMAGLUTIDE

ORAL SEMAGLUTIDE was reported 78023 times

ORAL SEMAGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYCLIC VOMITING SYNDROME 447 0.6107
1 IMPAIRED GASTRIC EMPTYING 4175 0.3060
2 GASTRIC HYPOMOTILITY 88 0.2866
3 CORRECTIVE LENS USER 242 0.2485
4 GASTROINTESTINAL HYPOMOTILITY 511 0.2265
5 OPTIC ISCHAEMIC NEUROPATHY 838 0.2163
6 PRODUCT DOSE CONFUSION 73 0.2056
7 MEDULLARY THYROID CANCER 63 0.1853
8 DRUG DOSE TITRATION NOT PERFORMED 233 0.1271
9 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 32 0.1260
10 DEVICE USE CONFUSION 61 0.1166
11 WEIGHT LOSS POOR 582 0.1137
12 LACK OF SATIETY 28 0.1073
13 GLYCOSYLATED HAEMOGLOBIN DECREASED 163 0.1012
14 PRODUCT INFORMATION CONTENT COMPLAINT 28 0.1004
15 FOOD CRAVING 463 0.0879
16 PRODUCT COMMUNICATION ISSUE 766 0.0867
17 SKIN LAXITY 37 0.0845
18 GALLBLADDER INJURY 161 0.0826
19 OBSTRUCTIVE PANCREATITIS 62 0.0810
20 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 89 0.0743
21 ALLODYNIA 85 0.0727
22 FOOD AVERSION 120 0.0706
23 PRODUCT LABEL CONFUSION 397 0.0680
24 HUNGER 885 0.0635
25 HEARING AID USER 26 0.0605
26 ILEUS 745 0.0599
27 ERUCTATION 1103 0.0569
28 DIABETIC RETINOPATHY 171 0.0503
29 DRUG TITRATION ERROR 129 0.0499
30 THIRST DECREASED 31 0.0494
31 GLYCOSYLATED HAEMOGLOBIN INCREASED 1231 0.0487
32 INCREASED APPETITE 918 0.0480
33 EUGLYCAEMIC DIABETIC KETOACIDOSIS 198 0.0479
34 PRODUCT CONFUSION 38 0.0479
35 COUNTERFEIT PRODUCT ADMINISTERED 60 0.0460
36 EARLY SATIETY 88 0.0452
37 INCORRECT DOSE ADMINISTERED BY PRODUCT 71 0.0443
38 INJECTION SITE DISCHARGE 222 0.0412
39 CATARACT OPERATION 234 0.0394
40 THYROID MASS 143 0.0372
41 METABOLIC SURGERY 41 0.0360
42 APPETITE DISORDER 237 0.0357
43 PANCREATITIS NECROTISING 81 0.0352
44 INTESTINAL OBSTRUCTION 1310 0.0347
45 COLONOSCOPY 74 0.0336
46 PRODUCT AFTER TASTE 32 0.0335
47 HYPERPHAGIA 130 0.0326
48 RETINOPATHY 118 0.0316
49 DIABETES MELLITUS INADEQUATE CONTROL 552 0.0311
50 VOMITING PROJECTILE 89 0.0307
51 PAPILLARY THYROID CANCER 53 0.0305
52 PRODUCT PACKAGING DIFFICULT TO OPEN 79 0.0302
53 ABNORMAL LOSS OF WEIGHT 206 0.0302
54 GASTROINTESTINAL SOUNDS ABNORMAL 149 0.0300
55 STARVATION 25 0.0300
56 CHOLECYSTITIS 343 0.0288
57 BLOOD GLUCOSE DECREASED 1354 0.0282
58 BILIARY COLIC 82 0.0282
59 ADENOCARCINOMA PANCREAS 35 0.0272
60 NECK MASS 75 0.0265
61 OBSTRUCTIVE SLEEP APNOEA SYNDROME 37 0.0254
62 PANCREATITIS 1337 0.0253
63 HICCUPS 204 0.0248
64 HYPOGLYCAEMIC UNCONSCIOUSNESS 49 0.0247
65 MEDICAL PROCEDURE 41 0.0246
66 BINGE EATING 26 0.0241
67 KETOSIS 26 0.0240
68 NEAR DEATH EXPERIENCE 79 0.0239
69 PANCREATIC FAILURE 42 0.0237
70 INFREQUENT BOWEL MOVEMENTS 59 0.0237
71 PANCREATIC CYST 45 0.0235
72 FEEDING DISORDER 468 0.0231
73 MALNUTRITION 258 0.0230
74 CONSTIPATION 4976 0.0228
75 PRODUCT STORAGE ISSUE 85 0.0224
76 OFF LABEL USE OF DEVICE 30 0.0222
77 BLOOD GLUCOSE FLUCTUATION 242 0.0221
78 DECREASED APPETITE 5107 0.0220
79 BOWEL MOVEMENT IRREGULARITY 161 0.0210
80 INSULIN RESISTANCE 43 0.0206
81 INJECTION SITE VESICLES 121 0.0200
82 TASTE DISORDER 404 0.0199
83 PRODUCT USED FOR UNKNOWN INDICATION 25 0.0199
84 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 122 0.0197
85 MUSCLE ATROPHY 244 0.0192
86 PANCREATIC ENZYMES INCREASED 28 0.0191
87 FEAR OF INJECTION 135 0.0189
88 DIABETIC KETOACIDOSIS 453 0.0188
89 FLATULENCE 1062 0.0187
90 CHOLELITHIASIS 609 0.0186
91 BLOOD GLUCOSE INCREASED 3460 0.0183
92 ILLNESS 1861 0.0180
93 REGURGITATION 62 0.0180
94 SENSITIVE SKIN 133 0.0180
95 DISABILITY 354 0.0179
96 SHOULDER FRACTURE 29 0.0177
97 LIPASE INCREASED 135 0.0176
98 DYSPEPSIA 1726 0.0175
99 SUSPECTED COUNTERFEIT PRODUCT 69 0.0174
100 CHOLECYSTECTOMY 197 0.0172
101 BREATH ODOUR 42 0.0172
102 WEIGHT DECREASED 4777 0.0171
103 COLITIS ISCHAEMIC 114 0.0169
104 ABDOMINAL DISTENSION 1760 0.0168
105 PANCREATIC DISORDER 83 0.0168
106 EYE OPERATION 77 0.0167
107 BILE DUCT STONE 53 0.0166
108 KETOACIDOSIS 124 0.0166
109 PRODUCT DISPENSING ERROR 358 0.0164
110 WEIGHT FLUCTUATION 170 0.0162
111 PANCREATIC CARCINOMA METASTATIC 46 0.0162
112 GASTRIC BYPASS 35 0.0161
113 PRODUCT DISPENSING ISSUE 68 0.0159
114 INJECTION SITE INDENTATION 34 0.0157
115 BRAIN FOG 245 0.0156
116 VOMITING 7332 0.0156
117 ABDOMINAL PAIN UPPER 3197 0.0155
118 DEHYDRATION 2062 0.0154
119 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3100 0.0153
120 RETCHING 324 0.0152
121 PRODUCT USE IN UNAPPROVED INDICATION 3761 0.0152
122 CHOLECYSTITIS INFECTIVE 42 0.0151
123 DISCOURAGEMENT 35 0.0150
124 PANCREATITIS CHRONIC 35 0.0148
125 GASTROINTESTINAL PAIN 161 0.0146
126 BLOOD GLUCOSE ABNORMAL 265 0.0143
127 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2549 0.0141
128 VITREOUS HAEMORRHAGE 39 0.0141
129 NAUSEA 11150 0.0141
130 MULTIPLE USE OF SINGLE-USE PRODUCT 79 0.0141
131 CARDIAC ABLATION 25 0.0140
132 HERNIA REPAIR 36 0.0139
133 AMYLASE INCREASED 50 0.0135
134 SPINAL OPERATION 166 0.0135
135 SMALL INTESTINAL OBSTRUCTION 165 0.0134
136 FAECES HARD 52 0.0134
137 PANCREATITIS ACUTE 300 0.0133
138 GASTROINTESTINAL DISORDER 1175 0.0131
139 FOOD INTOLERANCE 48 0.0131
140 FOOD POISONING 70 0.0131
141 VISUAL IMPAIRMENT 1600 0.0129
142 WEIGHT INCREASED 2869 0.0128
143 DYSCHEZIA 39 0.0128
144 SPINAL STENOSIS 52 0.0126
145 RETINAL TEAR 31 0.0126
146 BLINDNESS UNILATERAL 177 0.0125
147 ANAL INCONTINENCE 112 0.0124
148 WRONG DOSE 30 0.0124
149 LARGE INTESTINAL OBSTRUCTION 27 0.0121
150 VITREOUS DETACHMENT 26 0.0120
151 DIABETIC NEUROPATHY 59 0.0119
152 VOLVULUS 28 0.0118
153 EYELID PAIN 24 0.0118
154 EMOTIONAL DISTRESS 1403 0.0116
155 SHOULDER OPERATION 49 0.0115
156 KNEE OPERATION 112 0.0114
157 PRODUCT ADMINISTRATION INTERRUPTED 89 0.0113
158 GASTROOESOPHAGEAL REFLUX DISEASE 906 0.0112
159 GLOMERULAR FILTRATION RATE DECREASED 138 0.0112
160 POSTMENOPAUSAL HAEMORRHAGE 29 0.0111
161 RETINAL DETACHMENT 101 0.0110
162 THERAPEUTIC REACTION TIME DECREASED 32 0.0110
163 CARDIAC OPERATION 93 0.0108
164 GASTROENTERITIS VIRAL 193 0.0107
165 SKIN WRINKLING 29 0.0107
166 DIARRHOEA 6833 0.0106
167 INCORRECT DOSE ADMINISTERED BY DEVICE 277 0.0106
168 ABDOMINAL PAIN 2450 0.0105
169 PAROSMIA 79 0.0105
170 CHOLECYSTITIS ACUTE 59 0.0104
171 SHOULDER ARTHROPLASTY 28 0.0104
172 RENAL PAIN 109 0.0103
173 DEPRESSION SUICIDAL 35 0.0101
174 MENISCUS INJURY 62 0.0101
175 LIMB OPERATION 48 0.0100
176 INTESTINAL ISCHAEMIA 55 0.0100
177 PANCREATIC CARCINOMA 288 0.0100
178 ABDOMINAL DISCOMFORT 1653 0.0098
179 THYROID NEOPLASM 27 0.0098
180 FAECES SOFT 71 0.0098
181 VITAMIN B12 DECREASED 28 0.0097
182 GASTROINTESTINAL MOTILITY DISORDER 52 0.0097
183 GASTROINTESTINAL INJURY 26 0.0097
184 VITREOUS FLOATERS 95 0.0097
185 KNEE ARTHROPLASTY 203 0.0096
186 GALLBLADDER OPERATION 39 0.0096
187 DIVERTICULUM INTESTINAL 42 0.0096
188 EPIGASTRIC DISCOMFORT 37 0.0095
189 ILEUS PARALYTIC 42 0.0094
190 SKIN ODOUR ABNORMAL 37 0.0094
191 URINE ODOUR ABNORMAL 55 0.0093
192 THIRST 167 0.0093
193 BLINDNESS 380 0.0093
194 APPENDICITIS 87 0.0093
195 FAECALOMA 51 0.0093
196 FUNCTIONAL GASTROINTESTINAL DISORDER 32 0.0092
197 CATARACT 550 0.0092
198 HYPOGLYCAEMIA 446 0.0092
199 GALLBLADDER DISORDER 163 0.0091
200 OVERWEIGHT 49 0.0091
201 SLUGGISHNESS 93 0.0091
202 DEPRESSIVE SYMPTOM 32 0.0091
203 OFF LABEL USE 7890 0.0090
204 PHARYNGEAL SWELLING 88 0.0090
205 VISION BLURRED 1230 0.0089
206 SURGERY 522 0.0089
207 FOOT OPERATION 44 0.0089
208 DRUG EFFECT LESS THAN EXPECTED 131 0.0088
209 PRODUCT USE COMPLAINT 139 0.0088
210 LIQUID PRODUCT PHYSICAL ISSUE 64 0.0088
211 LACTIC ACIDOSIS 281 0.0087
212 INFUSION SITE PRURITUS 27 0.0085
213 NECROTISING FASCIITIS 30 0.0085
214 HYPOPHAGIA 216 0.0084
215 SPINAL FUSION SURGERY 34 0.0084
216 WALKING AID USER 55 0.0083
217 HIP SURGERY 45 0.0083
218 AGEUSIA 206 0.0082
219 GASTRITIS 217 0.0082
220 GASTROINTESTINAL NECROSIS 24 0.0082
221 AUTOIMMUNE THYROIDITIS 31 0.0082
222 PAPILLOEDEMA 37 0.0082
223 EYE HAEMORRHAGE 109 0.0082
224 DEVICE MALFUNCTION 573 0.0081
225 CONCUSSION 63 0.0081
226 GLUCOSE TOLERANCE IMPAIRED 48 0.0081
227 PRODUCT PRESCRIBING ERROR 193 0.0081
228 GASTROENTERITIS 118 0.0081
229 ASPIRATION 88 0.0080
230 RETINAL HAEMORRHAGE 57 0.0080
231 FLUID INTAKE REDUCED 40 0.0080
232 FEELING JITTERY 151 0.0079
233 HYPOVOLAEMIA 46 0.0079
234 OROPHARYNGEAL DISCOMFORT 71 0.0079
235 DEFAECATION URGENCY 55 0.0078
236 APPENDICECTOMY 28 0.0078
237 OPTIC NEURITIS 71 0.0078
238 DIVERTICULITIS 216 0.0078
239 IMPAIRED QUALITY OF LIFE 112 0.0078
240 HEPATIC STEATOSIS 145 0.0078
241 POST-TRAUMATIC STRESS DISORDER 52 0.0078
242 NEPHROLITHIASIS 352 0.0077
243 FOREIGN BODY IN THROAT 24 0.0076
244 OESOPHAGEAL PAIN 30 0.0076
245 FLANK PAIN 71 0.0076
246 GOITRE 31 0.0076
247 ADVERSE DRUG REACTION 666 0.0074
248 VULVOVAGINAL MYCOTIC INFECTION 29 0.0074
249 SEASONAL ALLERGY 104 0.0073
250 TRIGGER FINGER 30 0.0073
251 HYPOACUSIS 315 0.0073
252 VULVOVAGINAL PRURITUS 37 0.0073
253 HEPATIC PAIN 31 0.0073
254 REHABILITATION THERAPY 28 0.0072
255 MACULAR DEGENERATION 86 0.0072
256 ABNORMAL FAECES 59 0.0072
257 SELF-INJURIOUS IDEATION 30 0.0071
258 THYROID CANCER 86 0.0071
259 MACULAR OEDEMA 40 0.0071
260 SCIATICA 112 0.0070
261 INFUSION SITE SWELLING 44 0.0070
262 PRODUCT PACKAGING ISSUE 66 0.0069
263 INJURY ASSOCIATED WITH DEVICE 141 0.0069
264 EATING DISORDER 147 0.0069
265 HYPERVOLAEMIA 34 0.0069
266 DEVICE MECHANICAL ISSUE 94 0.0068
267 ABDOMINAL TENDERNESS 34 0.0068
268 TONGUE DISCOMFORT 29 0.0068
269 CHOLANGITIS 42 0.0068
270 SENSATION OF FOREIGN BODY 57 0.0068
271 POLLAKIURIA 282 0.0068
272 EXTRA DOSE ADMINISTERED 271 0.0067
273 LIMB INJURY 181 0.0067
274 INJECTION SITE DISCOLOURATION 83 0.0066
275 DIZZINESS POSTURAL 64 0.0066
276 URINE ABNORMALITY 30 0.0066
277 BLINDNESS TRANSIENT 48 0.0065
278 COVID-19 1140 0.0065
279 BLOOD CHOLESTEROL ABNORMAL 30 0.0065
280 FUNGAL INFECTION 214 0.0064
281 INFUSION SITE ERYTHEMA 54 0.0064
282 PRESYNCOPE 154 0.0063
283 HIATUS HERNIA 82 0.0063
284 SUNBURN 47 0.0063
285 WHEELCHAIR USER 28 0.0063
286 PRODUCT DOSE OMISSION IN ERROR 177 0.0062
287 RENAL FUNCTION TEST ABNORMAL 29 0.0062
288 RESPIRATION ABNORMAL 43 0.0062
289 VISUAL FIELD DEFECT 45 0.0062
290 NEEDLE ISSUE 181 0.0062
291 HIP ARTHROPLASTY 95 0.0062
292 FRUSTRATION TOLERANCE DECREASED 50 0.0062
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 297 0.0062
294 FREQUENT BOWEL MOVEMENTS 167 0.0062
295 BLOOD POTASSIUM DECREASED 185 0.0061
296 BLOOD MAGNESIUM DECREASED 53 0.0061
297 INTENTIONAL DOSE OMISSION 175 0.0061
298 TOE AMPUTATION 31 0.0061
299 BLOOD CREATINE INCREASED 27 0.0061
300 PRODUCT USE ISSUE 1146 0.0061
301 COLD SWEAT 107 0.0061
302 MUCOUS STOOLS 30 0.0061
303 NERVOUSNESS 314 0.0060
304 DEVICE LEAKAGE 259 0.0060
305 UNEVALUABLE EVENT 448 0.0059
306 LARGE INTESTINE POLYP 41 0.0059
307 BLOOD IRON DECREASED 70 0.0059
308 OCULAR DISCOMFORT 66 0.0059
309 ABSCESS LIMB 25 0.0059
310 ACCIDENT 70 0.0059
311 INABILITY TO AFFORD MEDICATION 58 0.0058
312 STENT PLACEMENT 47 0.0058
313 POLYP 38 0.0058
314 MUSCLE STRAIN 50 0.0058
315 ROTATOR CUFF SYNDROME 74 0.0058
316 ENERGY INCREASED 34 0.0058
317 KIDNEY INFECTION 113 0.0058
318 MAJOR DEPRESSION 42 0.0057
319 EYE DISORDER 188 0.0057
320 DEVICE FAILURE 87 0.0057
321 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97 0.0057
322 THYROID DISORDER 88 0.0057
323 ABDOMINAL HERNIA 26 0.0057
324 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24 0.0057
325 THERAPY CHANGE 56 0.0057
326 DRY MOUTH 462 0.0057
327 IRRITABLE BOWEL SYNDROME 122 0.0057
328 INSURANCE ISSUE 87 0.0057
329 SUICIDAL IDEATION 520 0.0057
330 SLEEP APNOEA SYNDROME 108 0.0057
331 HYSTERECTOMY 49 0.0057
332 ASTHENOPIA 31 0.0056
333 LETHARGY 323 0.0056
334 MULTIPLE ALLERGIES 44 0.0056
335 BIPOLAR DISORDER 61 0.0056
336 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 262 0.0056
337 PRODUCT DISTRIBUTION ISSUE 52 0.0056
338 PRODUCT LABEL ISSUE 38 0.0056
339 HYPERAESTHESIA 46 0.0056
340 INFUSION SITE PAIN 72 0.0056
341 FAECES DISCOLOURED 121 0.0056
342 MUSCULOSKELETAL DISCOMFORT 96 0.0056
343 ASTHENIA 2097 0.0056
344 JOINT INJURY 119 0.0056
345 CARPAL TUNNEL SYNDROME 78 0.0056
346 CARDIAC FLUTTER 36 0.0056
347 DIARRHOEA HAEMORRHAGIC 52 0.0056
348 VITAMIN D DEFICIENCY 54 0.0055
349 HEPATIC CIRRHOSIS 104 0.0055
350 HERNIA 107 0.0055
351 DIZZINESS 2719 0.0054
352 ANAL FISSURE 29 0.0054
353 DEPRESSION 1225 0.0054
354 NOCTURIA 65 0.0053
355 INJECTION SITE MASS 198 0.0053
356 RENAL DISORDER 249 0.0053
357 RALES 31 0.0053
358 WRONG PRODUCT ADMINISTERED 36 0.0053
359 CORONARY ARTERIAL STENT INSERTION 27 0.0053
360 APHONIA 74 0.0053
361 VENTRICULAR EXTRASYSTOLES 55 0.0053
362 GLAUCOMA 101 0.0052
363 UPPER-AIRWAY COUGH SYNDROME 43 0.0052
364 CORONARY ARTERY BYPASS 30 0.0052
365 CARDIAC PACEMAKER INSERTION 31 0.0052
366 MYASTHENIA GRAVIS 42 0.0052
367 DEPRESSED MOOD 274 0.0052
368 POSTOPERATIVE WOUND INFECTION 35 0.0052
369 ACUTE KIDNEY INJURY 793 0.0052
370 HEADACHE 3240 0.0052
371 DRUG INTOLERANCE 499 0.0052
372 BLOOD TRIGLYCERIDES INCREASED 91 0.0051
373 PRODUCT DOSE OMISSION ISSUE 1514 0.0051
374 POLYURIA 42 0.0051
375 DEAFNESS UNILATERAL 28 0.0051
376 INITIAL INSOMNIA 52 0.0051
377 BREAST MASS 34 0.0051
378 HYPERGLYCAEMIA 183 0.0050
379 SUPRAVENTRICULAR TACHYCARDIA 48 0.0050
380 DYSGEUSIA 369 0.0050
381 INJECTION SITE BRUISING 396 0.0050
382 LOCALISED INFECTION 120 0.0050
383 CHROMATURIA 112 0.0050
384 MEMORY IMPAIRMENT 679 0.0049
385 NEURALGIA 120 0.0049
386 BLOOD PRESSURE DECREASED 327 0.0049
387 DRY THROAT 50 0.0049
388 DECREASED INTEREST 29 0.0049
389 LYMPHOEDEMA 34 0.0049
390 INFLUENZA 547 0.0049
391 NERVE COMPRESSION 45 0.0049
392 BACK INJURY 53 0.0049
393 HAEMORRHOIDS 95 0.0049
394 GOUT 87 0.0048
395 SKIN SWELLING 42 0.0048
396 BLOOD PRESSURE ABNORMAL 96 0.0048
397 URINARY TRACT INFECTION 823 0.0048
398 BLOOD URINE PRESENT 91 0.0048
399 POOR VENOUS ACCESS 49 0.0047
400 HEAD INJURY 149 0.0047
401 ARTERIAL OCCLUSIVE DISEASE 37 0.0047
402 SKIN LACERATION 51 0.0047
403 NERVE INJURY 52 0.0047
404 OESOPHAGITIS 51 0.0047
405 ANXIETY 1325 0.0047
406 PRODUCT LEAKAGE 26 0.0046
407 FEELING ABNORMAL 1110 0.0046
408 MALAISE 2024 0.0046
409 PERIORBITAL SWELLING 26 0.0046
410 CEREBRAL DISORDER 34 0.0046
411 HEART RATE INCREASED 455 0.0046
412 ARTHROPOD BITE 34 0.0046
413 PHOTOPHOBIA 86 0.0046
414 BEDRIDDEN 60 0.0046
415 POST PROCEDURAL INFECTION 37 0.0045
416 ABDOMINAL PAIN LOWER 115 0.0045
417 DIABETES MELLITUS 345 0.0045
418 LOW DENSITY LIPOPROTEIN INCREASED 35 0.0045
419 SYMPTOM RECURRENCE 27 0.0045
420 PROCTALGIA 29 0.0045
421 ARTHRITIS 354 0.0045
422 TOOTH EXTRACTION 56 0.0045
423 ALOPECIA 881 0.0045
424 ILL-DEFINED DISORDER 271 0.0045
425 NECK PAIN 249 0.0045
426 LIGAMENT SPRAIN 44 0.0044
427 EYE PAIN 251 0.0044
428 CORONARY ARTERY OCCLUSION 61 0.0044
429 BLOOD CALCIUM INCREASED 39 0.0044
430 VERTIGO 271 0.0044
431 MUSCLE SPASMS 814 0.0044
432 PANIC REACTION 32 0.0044
433 FOOT FRACTURE 84 0.0044
434 PHOTOPSIA 28 0.0044
435 HAEMATEMESIS 112 0.0044
436 IMPAIRED WORK ABILITY 94 0.0044
437 OBESITY 70 0.0044
438 ANKLE FRACTURE 68 0.0044
439 APATHY 64 0.0044
440 HIDRADENITIS 40 0.0044
441 DEVICE DEFECTIVE 76 0.0044
442 ENTERITIS 28 0.0044
443 URINE OUTPUT DECREASED 38 0.0043
444 FEELING COLD 121 0.0043
445 SINUS DISORDER 86 0.0043
446 PRODUCT STORAGE ERROR 380 0.0043
447 TYPE 1 DIABETES MELLITUS 26 0.0043
448 BACK DISORDER 70 0.0043
449 METABOLIC DISORDER 25 0.0043
450 ELECTROLYTE IMBALANCE 50 0.0043
451 PERIPHERAL COLDNESS 59 0.0043
452 LOSS OF CONSCIOUSNESS 549 0.0043
453 ERECTILE DYSFUNCTION 110 0.0043
454 BACK PAIN 994 0.0043
455 COLITIS 162 0.0043
456 CONDITION AGGRAVATED 1299 0.0043
457 GAIT INABILITY 142 0.0042
458 IRON DEFICIENCY ANAEMIA 39 0.0042
459 HEAVY MENSTRUAL BLEEDING 38 0.0042
460 ONYCHOCLASIS 29 0.0042
461 PRODUCT ODOUR ABNORMAL 44 0.0042
462 MUSCULOSKELETAL CHEST PAIN 65 0.0042
463 PANIC ATTACK 153 0.0042
464 DYSPHONIA 245 0.0042
465 ROAD TRAFFIC ACCIDENT 175 0.0042
466 POOR QUALITY SLEEP 90 0.0042
467 FATIGUE 3252 0.0042
468 DIALYSIS 59 0.0042
469 FOOD ALLERGY 32 0.0041
470 PALPITATIONS 485 0.0041
471 SWELLING OF EYELID 26 0.0041
472 INJECTION SITE EXTRAVASATION 51 0.0041
473 NASOPHARYNGITIS 761 0.0041
474 PRODUCT AVAILABILITY ISSUE 94 0.0041
475 APHTHOUS ULCER 32 0.0041
476 MIDDLE INSOMNIA 77 0.0041
477 CYST 51 0.0041
478 METABOLIC ACIDOSIS 131 0.0041
479 TOOTH INFECTION 54 0.0041
480 PARAESTHESIA ORAL 59 0.0041
481 DRY EYE 204 0.0041
482 INCORRECT DOSE ADMINISTERED 931 0.0041
483 DEVICE DIFFICULT TO USE 269 0.0041
484 EAR INFECTION 108 0.0041
485 VIRAL INFECTION 135 0.0041
486 MYOPATHY 35 0.0040
487 DIPLOPIA 105 0.0040
488 ARTERIOSCLEROSIS 38 0.0040
489 HYPERHIDROSIS 520 0.0040
490 DERMATITIS CONTACT 46 0.0040
491 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
492 HYPERSOMNIA 115 0.0040
493 HEAD DISCOMFORT 71 0.0040
494 HOT FLUSH 302 0.0040
495 EAR DISCOMFORT 41 0.0040
496 DYSURIA 147 0.0040
497 THROAT IRRITATION 179 0.0040
498 PEMPHIGOID 30 0.0040
499 INCONTINENCE 42 0.0040
500 BLOOD POTASSIUM INCREASED 64 0.0039
501 DEMENTIA 110 0.0039
502 WRIST FRACTURE 47 0.0039
503 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
504 RENAL CYST 31 0.0039
505 TREMOR 646 0.0039
506 FALL 1290 0.0039
507 HYPERTHYROIDISM 56 0.0039
508 RHINORRHOEA 250 0.0039
509 ORTHOSTATIC HYPOTENSION 67 0.0038
510 BLOOD PRESSURE INCREASED 588 0.0038
511 BREAST PAIN 41 0.0038
512 BLOOD CHOLESTEROL INCREASED 179 0.0038
513 COLON CANCER 57 0.0038
514 OSTEOARTHRITIS 162 0.0038
515 PERIPHERAL SWELLING 587 0.0038
516 PAIN OF SKIN 102 0.0038
517 PRODUCT SUPPLY ISSUE 27 0.0038
518 ARTERIOSCLEROSIS CORONARY ARTERY 25 0.0038
519 TYPE 2 DIABETES MELLITUS 127 0.0038
520 BURNING SENSATION 264 0.0038
521 PULMONARY MASS 56 0.0038
522 OROPHARYNGEAL PAIN 348 0.0038
523 ACCIDENTAL OVERDOSE 137 0.0037
524 SKIN MASS 25 0.0037
525 SINUSITIS 382 0.0037
526 RASH PRURITIC 201 0.0037
527 LACRIMATION INCREASED 112 0.0037
528 DENTAL CARIES 41 0.0037
529 NEUROPATHY PERIPHERAL 352 0.0037
530 HOSPITALISATION 568 0.0037
531 INJECTION SITE HAEMORRHAGE 295 0.0037
532 MIGRAINE 352 0.0037
533 INTENTIONAL PRODUCT USE ISSUE 323 0.0037
534 LIVER FUNCTION TEST INCREASED 79 0.0037
535 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0037
536 ATRIAL FIBRILLATION 356 0.0037
537 MASS 51 0.0036
538 CARDIAC DISORDER 341 0.0036
539 SPINAL OSTEOARTHRITIS 32 0.0036
540 CORONAVIRUS INFECTION 24 0.0036
541 SNEEZING 81 0.0036
542 PHARYNGITIS STREPTOCOCCAL 39 0.0036
543 FACIAL PAIN 32 0.0036
544 GASTROINTESTINAL INFECTION 32 0.0036
545 INJECTION SITE PAIN 1095 0.0036
546 INTESTINAL PERFORATION 40 0.0036
547 DRUG DOSE OMISSION BY DEVICE 279 0.0036
548 DISCOMFORT 217 0.0036
549 THERAPY INTERRUPTED 254 0.0036
550 ADVERSE REACTION 47 0.0035
551 TOOTH FRACTURE 39 0.0035
552 POOR QUALITY PRODUCT ADMINISTERED 37 0.0035
553 SYNCOPE 349 0.0035
554 CHRONIC KIDNEY DISEASE 265 0.0035
555 LOWER LIMB FRACTURE 67 0.0035
556 CYSTITIS 111 0.0035
557 NEOPLASM 40 0.0035
558 HYPERTENSION 735 0.0035
559 THERAPEUTIC RESPONSE SHORTENED 115 0.0035
560 MUSCLE DISORDER 28 0.0035
561 EYE INFECTION 39 0.0035
562 LIP SWELLING 115 0.0034
563 DYSPNOEA EXERTIONAL 130 0.0034
564 URINARY INCONTINENCE 102 0.0034
565 NASAL CONGESTION 202 0.0034
566 NEPHROPATHY 32 0.0034
567 LIMB DISCOMFORT 106 0.0034
568 INTENTIONAL UNDERDOSE 25 0.0034
569 UTERINE LEIOMYOMA 25 0.0034
570 RESTLESS LEGS SYNDROME 62 0.0034
571 TRANSIENT ISCHAEMIC ATTACK 115 0.0034
572 BLOOD SODIUM DECREASED 64 0.0034
573 LYMPHADENOPATHY 120 0.0034
574 CHILLS 396 0.0034
575 NEOPLASM MALIGNANT 224 0.0034
576 SENSORY LOSS 27 0.0034
577 PRURITUS 1284 0.0033
578 INJECTION SITE DISCOMFORT 35 0.0033
579 INSOMNIA 886 0.0033
580 GASTROINTESTINAL INFLAMMATION 26 0.0033
581 HYPOAESTHESIA ORAL 50 0.0033
582 HAEMATOCHEZIA 183 0.0033
583 TOOTHACHE 60 0.0033
584 UPPER LIMB FRACTURE 66 0.0033
585 ORAL DISCOMFORT 46 0.0033
586 AUTOIMMUNE DISORDER 32 0.0033
587 DEVICE USE ERROR 114 0.0033
588 ACIDOSIS 25 0.0033
589 TENDERNESS 34 0.0033
590 HEPATOMEGALY 32 0.0033
591 THERAPY CESSATION 167 0.0032
592 INJECTION SITE SWELLING 249 0.0032
593 INTERVERTEBRAL DISC DEGENERATION 30 0.0032
594 TENDON RUPTURE 40 0.0032
595 BALANCE DISORDER 280 0.0032
596 ATRIOVENTRICULAR BLOCK 25 0.0032
597 PRODUCTIVE COUGH 154 0.0032
598 BLADDER DISORDER 32 0.0032
599 THROAT TIGHTNESS 87 0.0032
600 HEART RATE IRREGULAR 72 0.0032
601 CHOKING 62 0.0032
602 ASTHMA 359 0.0032
603 FIBROMYALGIA 77 0.0032
604 FURUNCLE 25 0.0032
605 PSORIATIC ARTHROPATHY 128 0.0032
606 DECREASED ACTIVITY 34 0.0031
607 ARTHRALGIA 1309 0.0031
608 COVID-19 PNEUMONIA 37 0.0031
609 BURSITIS 38 0.0031
610 ACCIDENTAL UNDERDOSE 45 0.0031
611 POST PROCEDURAL COMPLICATION 60 0.0031
612 HYPOKALAEMIA 144 0.0031
613 RENAL IMPAIRMENT 262 0.0031
614 PRODUCT ADMINISTRATION ERROR 63 0.0031
615 MOOD ALTERED 85 0.0031
616 ANOSMIA 45 0.0031
617 FLUID RETENTION 158 0.0031
618 BRAIN INJURY 31 0.0031
619 CHEST PAIN 572 0.0031
620 DYSPHAGIA 293 0.0031
621 BLOOD PRESSURE FLUCTUATION 74 0.0031
622 MUSCULAR WEAKNESS 350 0.0031
623 EXOSTOSIS 28 0.0031
624 SWOLLEN TONGUE 95 0.0030
625 VITAMIN D DECREASED 26 0.0030
626 ESCHERICHIA INFECTION 25 0.0030
627 SCAR 52 0.0030
628 CELLULITIS 153 0.0030
629 MYALGIA 516 0.0030
630 SINUS CONGESTION 41 0.0030
631 SCRATCH 32 0.0030
632 CEREBROVASCULAR ACCIDENT 513 0.0030
633 CHEST DISCOMFORT 310 0.0030
634 HELICOBACTER INFECTION 31 0.0030
635 INJECTION SITE URTICARIA 74 0.0030
636 GINGIVAL PAIN 24 0.0030
637 RIB FRACTURE 62 0.0030
638 EXPOSURE VIA SKIN CONTACT 78 0.0030
639 PARALYSIS 43 0.0030
640 CONTUSION 289 0.0030
641 IMPAIRED DRIVING ABILITY 34 0.0030
642 ARTHROPATHY 166 0.0030
643 HEREDITARY ANGIOEDEMA 32 0.0030
644 HEPATIC CYTOLYSIS 38 0.0030
645 DYSSTASIA 87 0.0030
646 SKIN ULCER 77 0.0030
647 EYE PRURITUS 100 0.0030
648 SKIN HAEMORRHAGE 44 0.0030
649 SECRETION DISCHARGE 37 0.0030
650 PAIN IN EXTREMITY 866 0.0029
651 EYE IRRITATION 169 0.0029
652 BLOOD THYROID STIMULATING HORMONE INCREASED 27 0.0029
653 EAR PAIN 57 0.0029
654 FULL BLOOD COUNT ABNORMAL 31 0.0029
655 SWELLING 274 0.0029
656 UPPER RESPIRATORY TRACT INFECTION 135 0.0029
657 HEPATIC ENZYME INCREASED 199 0.0029
658 SLEEP DISORDER 206 0.0029
659 EXPIRED PRODUCT ADMINISTERED 97 0.0029
660 TINNITUS 134 0.0029
661 NODULE 38 0.0029
662 URINARY RETENTION 97 0.0029
663 PERSONALITY CHANGE 27 0.0029
664 MENSTRUAL DISORDER 24 0.0029
665 ANGINA PECTORIS 83 0.0029
666 IRRITABILITY 174 0.0029
667 BRONCHITIS 212 0.0029
668 LEUKAEMIA 27 0.0029
669 SOMNOLENCE 576 0.0029
670 COUGH 798 0.0028
671 INTENTIONAL PRODUCT MISUSE 249 0.0028
672 RECTAL HAEMORRHAGE 122 0.0028
673 BRAIN NEOPLASM 26 0.0028
674 BLOOD PRESSURE SYSTOLIC INCREASED 55 0.0028
675 UROSEPSIS 26 0.0028
676 THERAPEUTIC PRODUCT EFFECT DECREASED 126 0.0028
677 AMNESIA 183 0.0028
678 PRODUCT PRESCRIBING ISSUE 61 0.0028
679 SALIVARY HYPERSECRETION 28 0.0028
680 EYE DISCHARGE 29 0.0028
681 DEVICE DELIVERY SYSTEM ISSUE 76 0.0028
682 PRODUCT PREPARATION ERROR 57 0.0028
683 ULCER 44 0.0028
684 SKIN FISSURES 54 0.0028
685 HYPERLIPIDAEMIA 33 0.0028
686 QUALITY OF LIFE DECREASED 37 0.0028
687 RASH 1200 0.0028
688 CLOSTRIDIUM DIFFICILE INFECTION 60 0.0027
689 CONTRAINDICATED PRODUCT ADMINISTERED 83 0.0027
690 PHARYNGITIS 34 0.0027
691 SUDDEN DEATH 29 0.0027
692 HYPOAESTHESIA 409 0.0027
693 SPLENOMEGALY 32 0.0027
694 SARS-COV-2 TEST POSITIVE 36 0.0027
695 ORAL PAIN 61 0.0027
696 SKIN DISCOLOURATION 125 0.0027
697 MUSCLE TIGHTNESS 44 0.0027
698 DEAFNESS 71 0.0027
699 EYE SWELLING 101 0.0027
700 PROCEDURAL PAIN 75 0.0027
701 OCULAR HYPERAEMIA 128 0.0027
702 PAIN 1656 0.0027
703 FEELING HOT 165 0.0027
704 NIGHTMARE 93 0.0027
705 GASTRIC ULCER 51 0.0027
706 MULTIPLE ORGAN DYSFUNCTION SYNDROME 76 0.0027
707 JAUNDICE 72 0.0027
708 LIVER DISORDER 118 0.0027
709 DERMATITIS ATOPIC 140 0.0027
710 JOINT DISLOCATION 28 0.0026
711 HYPOTENSION 530 0.0026
712 ADRENAL INSUFFICIENCY 32 0.0026
713 BLOOD TEST ABNORMAL 37 0.0026
714 ABSCESS 42 0.0026
715 MICTURITION URGENCY 30 0.0026
716 OXYGEN SATURATION DECREASED 147 0.0026
717 DISTURBANCE IN ATTENTION 141 0.0026
718 MENTAL DISORDER 113 0.0026
719 LYMPHOMA 40 0.0026
720 DEVICE ISSUE 232 0.0026
721 ORAL CANDIDIASIS 34 0.0026
722 RESPIRATORY TRACT CONGESTION 41 0.0026
723 SEPSIS 287 0.0026
724 SWELLING FACE 167 0.0026
725 TOOTH ABSCESS 26 0.0026
726 PARAESTHESIA 400 0.0025
727 GASTRIC DISORDER 87 0.0025
728 RESPIRATORY TRACT INFECTION 66 0.0025
729 BACTERIAL INFECTION 47 0.0025
730 METASTASES TO LIVER 44 0.0025
731 SKIN INFECTION 28 0.0025
732 INFLUENZA LIKE ILLNESS 204 0.0025
733 PULMONARY THROMBOSIS 27 0.0025
734 HERPES ZOSTER 142 0.0025
735 URTICARIA 414 0.0025
736 SCAB 28 0.0025
737 HEART RATE DECREASED 86 0.0024
738 INCORRECT PRODUCT ADMINISTRATION DURATION 53 0.0024
739 HOSPICE CARE 24 0.0024
740 CANDIDA INFECTION 41 0.0024
741 INTRAOCULAR PRESSURE INCREASED 31 0.0024
742 WHITE BLOOD CELL COUNT INCREASED 93 0.0024
743 BLISTER 136 0.0024
744 CONFUSIONAL STATE 391 0.0024
745 RENAL FAILURE 321 0.0024
746 HYPOTHYROIDISM 77 0.0024
747 CIRCULATORY COLLAPSE 41 0.0024
748 VASCULITIS 28 0.0024
749 HYPERSENSITIVITY 445 0.0024
750 COLITIS ULCERATIVE 107 0.0024
751 DYSPNOEA 1351 0.0024
752 TOOTH DISORDER 53 0.0024
753 LOWER RESPIRATORY TRACT INFECTION 108 0.0024
754 HYPOMAGNESAEMIA 33 0.0024
755 PROTEINURIA 45 0.0024
756 INTERNAL HAEMORRHAGE 27 0.0024
757 GAIT DISTURBANCE 451 0.0024
758 MYOCARDIAL INFARCTION 411 0.0024
759 BODY TEMPERATURE INCREASED 48 0.0024
760 SPINAL FRACTURE 47 0.0023
761 GENERALISED OEDEMA 29 0.0023
762 EUPHORIC MOOD 24 0.0023
763 ACUTE MYOCARDIAL INFARCTION 69 0.0023
764 NIGHT SWEATS 75 0.0023
765 PALLOR 63 0.0023
766 MALIGNANT MELANOMA 31 0.0023
767 BLOOD CREATININE INCREASED 150 0.0023
768 PAIN IN JAW 65 0.0023
769 HIP FRACTURE 73 0.0023
770 RASH MACULAR 79 0.0023
771 ARRHYTHMIA 107 0.0023
772 FOOT DEFORMITY 25 0.0023
773 ECZEMA 118 0.0023
774 THINKING ABNORMAL 42 0.0023
775 DEVICE BREAKAGE 91 0.0022
776 RESPIRATORY DISORDER 67 0.0022
777 MOOD SWINGS 71 0.0022
778 ANGER 75 0.0022
779 INJECTION SITE RASH 68 0.0022
780 MUSCULOSKELETAL STIFFNESS 192 0.0022
781 HEPATITIS 56 0.0022
782 ACCIDENTAL EXPOSURE TO PRODUCT 225 0.0022
783 INFLAMMATION 112 0.0022
784 SKIN EXFOLIATION 183 0.0022
785 DRUG INTERACTION 344 0.0022
786 FEAR 58 0.0022
787 IMMUNODEFICIENCY 32 0.0021
788 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 112 0.0021
789 ABORTION SPONTANEOUS 86 0.0021
790 HYPERKALAEMIA 75 0.0021
791 HYPOKINESIA 31 0.0021
792 MUSCLE TWITCHING 49 0.0021
793 MENTAL IMPAIRMENT 51 0.0021
794 THROMBOSIS 169 0.0021
795 ORAL HERPES 41 0.0021
796 GASTRIC HAEMORRHAGE 24 0.0021
797 TACHYCARDIA 185 0.0021
798 ACUTE RESPIRATORY FAILURE 40 0.0021
799 WHEEZING 123 0.0021
800 TOOTH LOSS 43 0.0021
801 RHABDOMYOLYSIS 86 0.0021
802 PHOTOSENSITIVITY REACTION 34 0.0021
803 JOINT STIFFNESS 54 0.0021
804 OSTEOMYELITIS 37 0.0020
805 RASH ERYTHEMATOUS 97 0.0020
806 DRY SKIN 269 0.0020
807 WOUND 56 0.0020
808 PRODUCT TASTE ABNORMAL 27 0.0020
809 PSORIASIS 260 0.0020
810 ANGIOEDEMA 88 0.0020
811 SKIN REACTION 28 0.0020
812 BLOOD CREATINE PHOSPHOKINASE INCREASED 57 0.0020
813 MATERNAL EXPOSURE DURING PREGNANCY 176 0.0020
814 INJECTION SITE IRRITATION 25 0.0020
815 PROSTATIC SPECIFIC ANTIGEN INCREASED 27 0.0020
816 THERAPY NON-RESPONDER 88 0.0020
817 DISEASE RECURRENCE 93 0.0020
818 SKIN BURNING SENSATION 140 0.0020
819 EPISTAXIS 146 0.0019
820 SEIZURE 225 0.0019
821 SPEECH DISORDER 102 0.0019
822 DEVICE USE ISSUE 34 0.0019
823 STAPHYLOCOCCAL INFECTION 64 0.0019
824 ANAPHYLACTIC REACTION 107 0.0019
825 COMPLICATION ASSOCIATED WITH DEVICE 28 0.0019
826 END STAGE RENAL DISEASE 35 0.0019
827 PULMONARY EMBOLISM 182 0.0019
828 BLOOD UREA INCREASED 32 0.0019
829 INJECTION SITE PRURITUS 126 0.0019
830 INJECTION SITE ERYTHEMA 233 0.0019
831 SHOCK 43 0.0019
832 VAGINAL HAEMORRHAGE 81 0.0019
833 PERICARDIAL EFFUSION 43 0.0019
834 ALANINE AMINOTRANSFERASE INCREASED 114 0.0019
835 OSTEOPENIA 28 0.0018
836 OEDEMA 100 0.0018
837 CARDIAC FAILURE CONGESTIVE 148 0.0018
838 LUNG DISORDER 90 0.0018
839 LABORATORY TEST ABNORMAL 54 0.0018
840 IMMUNE SYSTEM DISORDER 24 0.0018
841 INFECTION 261 0.0018
842 SKIN DISORDER 60 0.0018
843 MOBILITY DECREASED 129 0.0018
844 PRODUCT PHYSICAL ISSUE 36 0.0018
845 DYSARTHRIA 67 0.0018
846 LEUKOCYTOSIS 32 0.0018
847 IMPAIRED HEALING 58 0.0018
848 SINUS TACHYCARDIA 25 0.0018
849 BONE PAIN 103 0.0018
850 HYPONATRAEMIA 99 0.0018
851 SEPTIC SHOCK 76 0.0017
852 PNEUMONIA 565 0.0017
853 FRACTURE 33 0.0017
854 DISORIENTATION 69 0.0017
855 COGNITIVE DISORDER 81 0.0017
856 OSTEOPOROSIS 71 0.0017
857 SKIN CANCER 37 0.0017
858 ANHEDONIA 45 0.0017
859 TUBULOINTERSTITIAL NEPHRITIS 32 0.0017
860 ABNORMAL DREAMS 47 0.0017
861 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
862 PARANOIA 29 0.0017
863 PNEUMONIA ASPIRATION 42 0.0017
864 RED BLOOD CELL COUNT DECREASED 48 0.0017
865 DEEP VEIN THROMBOSIS 109 0.0017
866 ANAPHYLACTIC SHOCK 43 0.0017
867 HYPOXIA 58 0.0016
868 PNEUMOTHORAX 26 0.0016
869 HALLUCINATION, AUDITORY 26 0.0016
870 APHASIA 49 0.0016
871 CEREBRAL HAEMORRHAGE 58 0.0016
872 FLUSHING 163 0.0016
873 PSYCHOTIC DISORDER 47 0.0016
874 HYPOCALCAEMIA 30 0.0016
875 CHOLESTASIS 30 0.0016
876 THERAPEUTIC RESPONSE UNEXPECTED 70 0.0016
877 PYREXIA 538 0.0016
878 LIVER INJURY 38 0.0015
879 EJECTION FRACTION DECREASED 24 0.0015
880 INJURY 108 0.0015
881 TREATMENT NONCOMPLIANCE 84 0.0015
882 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 109 0.0015
883 MUSCULOSKELETAL DISORDER 29 0.0015
884 ISCHAEMIC STROKE 27 0.0015
885 PULMONARY FIBROSIS 29 0.0015
886 MELAENA 33 0.0015
887 OEDEMA PERIPHERAL 182 0.0015
888 CRYING 54 0.0015
889 RHEUMATOID ARTHRITIS 168 0.0015
890 RESTLESSNESS 54 0.0015
891 GENERAL PHYSICAL HEALTH DETERIORATION 170 0.0015
892 DRUG ERUPTION 26 0.0015
893 DRUG-INDUCED LIVER INJURY 46 0.0015
894 INJECTION SITE REACTION 100 0.0015
895 PULMONARY OEDEMA 65 0.0015
896 PULMONARY HYPERTENSION 30 0.0014
897 PELVIC PAIN 26 0.0014
898 HAEMATOMA 37 0.0014
899 CORONARY ARTERY DISEASE 43 0.0014
900 SKIN IRRITATION 65 0.0014
901 JOINT SWELLING 171 0.0014
902 VISUAL ACUITY REDUCED 47 0.0014
903 ASPARTATE AMINOTRANSFERASE INCREASED 75 0.0014
904 CARDIAC FAILURE 113 0.0014
905 CONJUNCTIVITIS 26 0.0014
906 HAEMORRHAGE 146 0.0014
907 EMOTIONAL DISORDER 43 0.0014
908 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
909 DRUG INEFFECTIVE 1821 0.0014
910 HEPATIC CANCER 33 0.0014
911 MOVEMENT DISORDER 44 0.0014
912 PRODUCT QUALITY ISSUE 186 0.0014
913 BREAST CANCER 127 0.0014
914 HALLUCINATION 102 0.0014
915 SKIN LESION 37 0.0013
916 ERYTHEMA 274 0.0013
917 BLOOD BILIRUBIN INCREASED 36 0.0013
918 COMPLICATION OF DEVICE REMOVAL 24 0.0013
919 CARDIAC ARREST 109 0.0013
920 THERAPEUTIC RESPONSE DECREASED 80 0.0013
921 BONE DISORDER 24 0.0013
922 RENAL INJURY 39 0.0013
923 CEREBRAL INFARCTION 32 0.0013
924 SEROTONIN SYNDROME 25 0.0013
925 AGITATION 95 0.0013
926 HAEMATURIA 44 0.0013
927 MUSCULOSKELETAL PAIN 67 0.0013
928 SYSTEMIC LUPUS ERYTHEMATOSUS 45 0.0013
929 COMA 60 0.0013
930 RASH PAPULAR 28 0.0012
931 CARDIOVASCULAR DISORDER 31 0.0012
932 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
933 LUNG NEOPLASM MALIGNANT 50 0.0012
934 HAEMATOCRIT DECREASED 24 0.0012
935 INFUSION RELATED REACTION 77 0.0012
936 HEPATIC FUNCTION ABNORMAL 43 0.0012
937 HAEMOGLOBIN DECREASED 115 0.0011
938 GLOSSODYNIA 25 0.0011
939 PRODUCT SUBSTITUTION ISSUE 64 0.0011
940 MULTIPLE SCLEROSIS 53 0.0011
941 SUICIDE ATTEMPT 67 0.0011
942 FEMUR FRACTURE 34 0.0011
943 DYSKINESIA 44 0.0011
944 GASTRIC CANCER 27 0.0011
945 NERVOUS SYSTEM DISORDER 33 0.0011
946 STOMATITIS 64 0.0011
947 ANAEMIA 199 0.0010
948 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
949 HEPATIC FAILURE 31 0.0010
950 WITHDRAWAL SYNDROME 43 0.0010
951 EPILEPSY 31 0.0010
952 ABNORMAL BEHAVIOUR 40 0.0010
953 HAEMOPTYSIS 28 0.0010
954 PLATELET COUNT DECREASED 106 0.0010
955 C-REACTIVE PROTEIN INCREASED 36 0.0010
956 MENSTRUATION IRREGULAR 26 0.0010
957 OVERDOSE 208 0.0010
958 LIVER FUNCTION TEST ABNORMAL 28 0.0010
959 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
960 PLEURAL EFFUSION 58 0.0010
961 MEDICATION ERROR 52 0.0009
962 WHITE BLOOD CELL COUNT DECREASED 101 0.0009
963 INTERSTITIAL LUNG DISEASE 45 0.0009
964 RENAL CANCER 44 0.0009
965 DELIRIUM 32 0.0009
966 ADVERSE EVENT 82 0.0009
967 AGGRESSION 44 0.0009
968 UNDERDOSE 64 0.0009
969 PROSTATE CANCER 70 0.0009
970 MENTAL STATUS CHANGES 24 0.0009
971 ACNE 64 0.0008
972 INTENTIONAL OVERDOSE 53 0.0008
973 PRODUCT DOSE OMISSION 44 0.0007
974 THROMBOCYTOPENIA 72 0.0006
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
976 CARDIO-RESPIRATORY ARREST 25 0.0006
977 BRADYCARDIA 31 0.0006
978 DEATH 495 0.0006
979 RESPIRATORY FAILURE 41 0.0006
980 BLADDER CANCER 29 0.0005
981 COMPLETED SUICIDE 41 0.0005
982 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
983 NO ADVERSE EVENT 78 0.0004
984 NEUTROPENIA 55 0.0004
985 DRUG ABUSE 31 0.0004
986 TOXICITY TO VARIOUS AGENTS 61 0.0004
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
988 DISEASE PROGRESSION 39 0.0003
989 MALIGNANT NEOPLASM PROGRESSION 29 0.0003